
There is a need for large, longer-duration phase II clinical trials that test the efficacy of intravenous vitamin C in cancer progression and overall survival. (More information)Ĭurrent evidence of the efficacy of intravenous vitamin C in cancer patients is limited to observational studies, uncontrolled interventions, and case reports. Randomized controlled trials have reported no effect of vitamin C supplementation on cancer risk. Most observational studies examining vitamin C intake in relation to cancer incidence have found no association. There are insufficient data to suggest a link between vitamin C status and the risk of developing a given type of cancer. There is some evidence to suggest that vitamin C may be a useful adjunct to conventional medical practice to reduce myocardial injury and arrhythmia following a cardiac procedure or surgery in patients with cardiovascular disease.

Healthcare Professional Continuing Education.

